Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-15-058116

Director sold 10,000 shares at $6.26 ($62,591)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kraus Al · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-10-01 Exercise or conversion : show line 1 in the form +10,000 $0.88 $8,750 65,746 D
2015-10-01 Sale : show line 2 in the form −10,000 $6.26 $62,591 55,746 D
Open-market sales · 10,000 sh · avg $6.26 · $62,591

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-10-01 Exercise or conversion : show line 3 in the form Stock Option −10,000 26,773 D
Loading xslF345X03/v421595_4.xml…